|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
CO-ADMINISTRATION WITH ANTIPLATELET AGENTS MAY BE ASSOCIATED WITH AN INCREASE IN BLEEDING.
|
CO-ADMINISTRATION WITH ANTIPLATELET AGENTS MAY BE ASSOCIATED WITH AN INCREASE IN BLEEDING.
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
POTENTIAL FOR INCREASED MYELOTOXICITY AND NEPHROTOXICITY
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
MAY INCREASE DIGOXIN ABSORPTION IN PATIENTS WHO INACTIVATE DIGOXIN BY BACTERIAL METABOLISM IN THE LOWER INTESTINE, SO THAT DIGITALIS INTOXICATION MAY RESULT
|
MAY INCREASE DIGOXIN ABSORPTION IN PATIENTS WHO INACTIVATE DIGOXIN BY BACTERIAL METABOLISM IN THE LOWER INTESTINE, SO THAT DIGITALIS INTOXICATION MAY RESULT
|
TETRACYCLINES CONCOMITANT USE MAY CAUSE BENIGN INTRACRANIAL HYPERTENSION
|
TETRACYCLINES CONCOMITANT USE MAY CAUSE BENIGN INTRACRANIAL HYPERTENSION
|
TETRACYCLINES CONCOMITANT USE MAY CAUSE BENIGN INTRACRANIAL HYPERTENSION
|
FOLIC ACID DEFICIENCY MAY PRECIPITATE WITH CONCURRENT USE
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
MAGNESIUM CONTAINING SALTS MAY INTERFERE WITH THE ABSORPTION OF THE DRUG
|
SOD MOLYBDATE DECREASES ABSORPTION OF THE DRUG
|
|
|
|
|
|
|
|
|
APROTININ IS INCOMPATIBLE WITH THE DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
MOLYBDENUM IMPAIRES THE ABSORPTION OF THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|